Meiping Chang

Dr. Meiping Chang

Merck and Co., Rahway, New Jersey, USA
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in iScience
Verified
Journal Article
Open access
SHSteve Huhn
Steve Huhn
MCMeiping Chang
Meiping Chang
AKAmit Kumar
Amit Kumar
RLRen Liu
Ren Liu
BJBo Jiang
Bo Jiang
ZDZhimei Du
Zhimei Du
Genetic instability of Chinese hamster ovary (CHO) cells is implicated in production inconsistency through poorly defined mechanisms. Using a multi-omics approach, we analyzed the variations of CHO lineages derived from CHO-K1 cells. We identify an equilibrium between random genetic variation of the CHO genome and heritable traits driven by culture conditions, selection criteria, and genetic linkage. These inherited changes are associated with the selection pressures related to serum removal, suspension culture transition, protein expression, and secretion. We observed that a haploid reduction of a Chromosome 2 region after serum-free, suspension adaptation, was consistently inherited, suggesting common adaptation mechanisms. Genetic variations also included ∼200 insertions/deletions, ∼1000 single-nucleotide polymorphisms, and ∼300–2000 copy number variations, which were exacerbated after gene editing. In addition, heterochromatic chromosomes were preferentially lost as cells continuously evolved. Together, these observations demonstrate a highly plastic signature for adapted CHO cells and paves the way towards future host cell engineering.

1 March 2016 in Drug Discovery Today
Verified
Journal Article
Closed access
MCMeiping Chang
Meiping Chang
MCMan Chang
Man Chang
JRJane Z. Reed
Jane Z. Reed
DMDavid Milward
David Milward
JXJinghai James Xu
Jinghai James Xu
WCWendy D. Cornell
Wendy D. Cornell

20 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
BHBrooks M. Hopkins
Brooks M. Hopkins
JFJustin Fisher
Justin Fisher
MCMeiping Chang
Meiping Chang
XTXiaoyan Tang
Xiaoyan Tang
ZDZhimei Du
Zhimei Du
Zuyi HuangZuyi Huang
Zuyi Huang
The growth of T cells ex vivo for the purpose of T cell therapies is a rate-limiting step in the overall process for cancer patients to achieve remission. Growing T cells is a fiscally-, time-, and resource-intensive process. Cytokines have been shown to accelerate the growth of T cells, specifically IL-2, IL-7, and IL-15. Here a design of experiments was conducted to optimize the growth rate of different naïve and memory T cell subsets using combinations of cytokines. Mathematical models were developed to study the impact of IL-2, IL-7, and IL-15 on the growth of T cells. The results show that CD4+ and CD8+ naïve T cells grew effectively using moderate IL-2 and IL-7 in combination, and IL-7, respectively. CD4+ and CD8+ memory cells favored moderate IL-2 and IL-15 in combination and moderate IL-7 and IL-15 in combination, respectively. A statistically significant interaction was observed between IL-2 and IL-7 in the growth data of CD4+ naïve T cells, while the interaction between IL-7 and IL-15 was found for CD8+ naïve T cells. The important genes and related signaling pathways and metabolic reactions were identified from the RNA sequencing data for each of the four subsets stimulated by each of the three cytokines. This systematic investigation lays the groundwork for studying other T cell subsets.

14 January 2022 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
MCMeiping Chang
Meiping Chang
AKAmit Kumar
Amit Kumar
SKSwetha Kumar
Swetha Kumar
SHSteven Huhn
Steven Huhn
WTWinston Timp
Winston Timp
ZDZhimei Du
Zhimei Du

3 February 2022 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
MCMeiping Chang
Meiping Chang
SHSteven Huhn
Steven Huhn
LNLuke Nelson
Luke Nelson
MBMichael J. Betenbaugh
Michael J. Betenbaugh
ZDZhimei Du
Zhimei Du

1 January 1999 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
PDF file
MCMeiping Chang
Meiping Chang
DNDean C. Norman
Dean C. Norman
The goal of this study was to determine whether alcohol affects alloantigen-induced proliferative and cytolytic activity of T cells in mice, and whether the altered immune response was in part due to a defect of IL-2 activity. The ability of spleen cells from individual alcohol-consuming C57BL/6 mice to generate allo-specific mixed lymphocyte response (MLR) and cytotoxic T lymphocyte (CTL) was compared to that of mice fed on an isocaloric maltose diet and regular diet. Allospecific MLR and CTL were generated by sensitizing spleen cells of C57BL/6 mice against spleen cells from BALB/c mice, and the allo-specific CTL activity was determined by the ability of the CTL to kill 51Cr-labeled P815 mastocytoma target cells. Our results showed that the allo-specific MLR of the responder cells from alcohol-consuming mice was significantly reduced (40% reduction, p > 0.01), and the addition of exogenous interleukin 2 (IL-2) could not reverse the suppression of MLR induced by ethanol. However, our results clearly showed that ethanol has little suppressive effect on allo-reactive CTL of alcohol-consuming mice as compared to the alloreactivity of the control mice (P < 0.05). Finally, we also demonstrated that ethanol did not impair the alloantigen-induced IL-2 production in the mixed lymphocyte cultures (P < 0.1). This study was supported by VA Medical Funds and a grant from the Alcoholic Beverage Medical Research Foundation. We are grateful to Mr. Jerry Sproul for help preparing this manuscript.